(Q36908540)

17 August 2017

1 reference

title

Should a statin be prescribed to every patient with heart failure? (English)

1 reference

17 August 2017

author

Dimitri P Mikhailidis

4

object named as

Dimitri P Mikhailidis

1 reference

17 August 2017

Evangelos N Liberopoulos

0 references

author name string

Sofia G Tsouli

1

1 reference

17 August 2017

Evangelos N Liberopoulos

2

1 reference

17 August 2017

John A Goudevenos

3

1 reference

17 August 2017

Moses S Elisaf

5

1 reference

17 August 2017

publication date

12 August 2007

1 reference

17 August 2017

number of pages

15

1 reference

inferred from page(s)

published in

Heart Failure Reviews

1 reference

17 August 2017

volume

13

1 reference

17 August 2017

issue

2

1 reference

17 August 2017

page(s)

211-225

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-007-9041-2

17 August 2017

exact match

0 references

cites work

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9041-2

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9041-2

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9041-2

Apoptosis and heart failure: A critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9041-2

Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9041-2

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9041-2

Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9041-2

Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of "Q-symbio"--a multinational trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9041-2

Statins and the role of nitric oxide in chronic heart failure

21 January 2018

1 reference

12 December 2020

Usefulness of atorvastatin in patients with heart failure due to inflammatory dilated cardiomyopathy and elevated cholesterol levels

1 reference

12 December 2020

The effect of cholesterol-lowering treatment on renal function

1 reference

12 December 2020

Statins and autonomic function in chronic heart failure

1 reference

12 December 2020

Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure

1 reference

12 December 2020

Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

1 reference

12 December 2020

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure

1 reference

12 December 2020

More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure

1 reference

12 December 2020

Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.

1 reference

12 December 2020

Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia

1 reference

12 December 2020

Serum uric acid levels as a predictor of in-hospital death in patients hospitalized for decompensated heart failure

1 reference

12 December 2020

Studies on the function of rho A protein in cardiac myofibrillogenesis

1 reference

12 December 2020

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

1 reference

12 December 2020

The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]

1 reference

12 December 2020

Rho GTPases in cell biology

1 reference

12 December 2020

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

1 reference

12 December 2020

Predictors of readmission among elderly survivors of admission with heart failure

1 reference

12 December 2020

Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Statin use and survival outcomes in elderly patients with heart failure

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Clinical use of Nebivolol in the treatment of chronic heart failure.

1 reference

12 December 2020

Some current controversies in heart failure (2004-2005)

1 reference

12 December 2020

Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study

1 reference

12 December 2020

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

12 December 2020

The effects of atorvastatin (10 mg) on systemic inflammation in heart failure

1 reference

12 December 2020

Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging

1 reference

12 December 2020

Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

1 reference

12 December 2020

Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein

1 reference

12 December 2020

Uric acid renal excretion and renal insufficiency in decompensated severe heart failure.

1 reference

12 December 2020

The endotoxin-lipoprotein hypothesis

1 reference

12 December 2020

Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure.

1 reference

12 December 2020

Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report

1 reference

12 December 2020

1 reference

12 December 2020

New-onset diabetes after transplantation

1 reference

12 December 2020

Preservation of NO production by statins in the treatment of heart failure

1 reference

12 December 2020

Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis

1 reference

12 December 2020

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

1 reference

12 December 2020

A review of the lipid-related effects of fluvastatin

1 reference

12 December 2020

Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.

1 reference

12 December 2020

Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure

1 reference

12 December 2020

Coronary artery disease as the cause of incident heart failure in the population

1 reference

12 December 2020

Inflammatory mediators in chronic heart failure: an overview

1 reference

12 December 2020

Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study.

1 reference

12 December 2020

Cardiac effects of statins--advancements and open questions

1 reference

12 December 2020

Diagnosis and management of the metabolic syndrome in obesity

1 reference

12 December 2020

Preventing type 2 diabetes in high risk patients: an overview of lifestyle and pharmacological measures.

1 reference

12 December 2020

Decreased heart rate recovery in patients with heart failure: effect of fluvastatin therapy

1 reference

12 December 2020

Changes in xanthine oxidase activity in patients with circulatory failure

1 reference

12 December 2020

Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure

1 reference

12 December 2020

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

1 reference

12 December 2020

Effects of lipid-lowering drugs on left ventricular function and exercise tolerance in dyslipidemic coronary patients

1 reference

12 December 2020

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

12 December 2020

Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology

1 reference

12 December 2020

The relationship between cholesterol and survival in patients with chronic heart failure

1 reference

12 December 2020

Protein lipidation in cell signaling

1 reference

12 December 2020

Immunological aspects of the statins' function in patients with heart failure: a report from the Annual Conference of ESC - Heart Failure 2005.

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

1 reference

12 December 2020

Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment

1 reference

12 December 2020

Fluvastatin and lifestyle modification for reduction of carotid intima-media thickness and left ventricular mass progression in drug-treated hypertensives

1 reference

12 December 2020

Adaptation and maladaptation of the heart in diabetes: Part I: general concepts

1 reference

12 December 2020

Statin mediated protection of the ischemic myocardium

1 reference

12 December 2020

C-Reactive protein in dilated cardiomyopathy

1 reference

12 December 2020

Short-term adjuvant atorvastatin improves frequency domain indices of heart rate variability in stable systolic heart failure

1 reference

12 December 2020

Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure

1 reference

12 December 2020

Early Withdrawal of Statin Therapy in Patients With Non–ST-Segment Elevation Myocardial Infarction National Registry of Myocardial Infarction

1 reference

12 December 2020

Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells

1 reference

12 December 2020

The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study.

1 reference

12 December 2020

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study

1 reference

12 December 2020

The antioxidant effects of statins may extend beyond atherosclerosis: potential benefits for atrial fibrillation and heart failure

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

1 reference

12 December 2020

Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe

1 reference

12 December 2020

Statins and mortality among elderly patients hospitalized with heart failure

1 reference

12 December 2020

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

1 reference

12 December 2020

Statins: another class of antihypertensive agents?

1 reference

12 December 2020

Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study.

1 reference

12 December 2020

Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function

1 reference

12 December 2020

Statin therapy is associated with lower mortality among patients with severe heart failure

1 reference

12 December 2020

Combined treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a review of the current evidence.

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Inflammatory mediators and the failing heart: past, present, and the foreseeable future

1 reference

12 December 2020

Early statin therapy in patients with acute coronary syndrome.

1 reference

12 December 2020

Simvastatin Normalizes Autonomic Neural Control in Experimental Heart Failure

1 reference

12 December 2020

Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study

1 reference

12 December 2020

The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease

1 reference

12 December 2020

Statin therapy in heart failure

1 reference

12 December 2020

Atrial fibrillation, inflammation and statins

1 reference

12 December 2020

Independent and incremental prognostic value of heart rate variability in patients with chronic heart failure

1 reference

12 December 2020

Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial

1 reference

12 December 2020

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

1 reference

12 December 2020

Rho GTPases and the actin cytoskeleton

1 reference

12 December 2020

Beneficial effects of statins in patients with non-ischemic heart failure

1 reference

12 December 2020

Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity

1 reference

12 December 2020

Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase

1 reference

12 December 2020

Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese

1 reference

12 December 2020

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

12 December 2020

Anemia and chronic kidney disease are associated with poor outcomes in heart failure patients

1 reference

12 December 2020

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

1 reference

12 December 2020

The role of statins in vascular disease

1 reference

12 December 2020

A novel pleiotropic effect of statins: prevention of cardiac hypertrophy by cholesterol-independent mechanisms

1 reference

12 December 2020

Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction

1 reference

12 December 2020

Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction.

1 reference

12 December 2020

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

12 December 2020

Pravastatin suppresses the increase in matrix metalloproteinase-2 levels after acute myocardial infarction

1 reference

12 December 2020

Prognostic significance of simvastatin therapy in patients with ischemic heart failure who underwent percutaneous coronary intervention for acute myocardial infarction

1 reference

12 December 2020

Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes.

1 reference

12 December 2020

Statins in the treatment of chronic heart failure: biological and clinical considerations

1 reference

12 December 2020

Statins associated with reduced mortality in patients admitted for congestive heart failure

1 reference

12 December 2020

Comparison of outcomes in acute coronary syndrome in patients receiving statins within 24 hours of onset versus at later times

1 reference

12 December 2020

A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics

1 reference

12 December 2020

Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles.

1 reference

12 December 2020

Antioxidant effects of statins

1 reference

12 December 2020

Isoprenoid metabolism and the pleiotropic effects of statins

1 reference

12 December 2020

Statin therapy is associated with improved cardiovascular outcomes and levels of inflammatory markers in patients with heart failure

1 reference

12 December 2020

Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study

1 reference

12 December 2020

Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure

1 reference

12 December 2020

Obesity and the risk of heart failure

1 reference

12 December 2020

Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study

1 reference

12 December 2020

Statins for heart failure: at the crossroads between cholesterol reduction and pleiotropism?

1 reference

12 December 2020

Effect of short-term treatment with pravastatin on cytokines and cytokine receptors in patients with chronic heart failure due to ischemic and nonischemic disease.

1 reference

12 December 2020

Metabolic syndrome and risk for heart failure in middle-aged men.

1 reference

12 December 2020

The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease

1 reference

12 December 2020

Low serum cholesterol levels predict high perioperative mortality in patients supported by a left-ventricular assist system

1 reference

12 December 2020

Statin therapy and risks for death and hospitalization in chronic heart failure

1 reference

12 December 2020

Overview of the relationship between ischemia and congestive heart failure

1 reference

12 December 2020

Uric acid in chronic heart failure: a marker of chronic inflammation

1 reference

12 December 2020

Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry

1 reference

12 December 2020

Statins for heart failure: a potential for new treatment

1 reference

12 December 2020

C-reactive protein and risk of heart failure. The Rotterdam Study

1 reference

12 December 2020

The impact of coenzyme Q10 on systolic function in patients with chronic heart failure

1 reference

12 December 2020

ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles

1 reference

12 December 2020

Statins and myocardial hypertrophy

1 reference

12 December 2020

Atorvastatin therapy associated with improvement in left ventricular remodeling in a case of idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?

1 reference

12 December 2020

Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans

1 reference

12 December 2020

Statins and renal function

1 reference

12 December 2020

Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure

1 reference

12 December 2020

Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure

1 reference

12 December 2020

Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

1 reference

12 December 2020

Nitric Oxide Protects Against Leukocyte-Endothelium Interactions in the Early Stages of Hypercholesterolemia

1 reference

12 December 2020

The emerging role of statins in the treatment of heart failure

1 reference

12 December 2020

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

12 December 2020

10.1007/S10741-007-9041-2

Identifiers

DOI

1 reference

17 August 2017

1 reference